RSS feed (help)
Media Releases
For more information on Media Releases contact our Communications Manager, 
Simon England, on 021 863 342.
Search for previous media releases
- Herceptin consultation ends (3 pages, 121 KB) 10 Jun 2008
- New migraine treatment could be on the tip of your tongue (1 page, 62 KB) 30 May 2008
- PHARMAC calls for public comment on review of advisory committee guidelines (1 page, 83 KB) 20 May 2008
- Hit the target - Antibiotic Campaign 2008 (2 pages, 280 KB) 13 May 2008
- Prescribing decline a healthy trend - PHARMAC (1 page, 720 KB) 13 May 2008
- Herceptin Background (5 pages, 57 KB) 05 May 2008
- Herceptin consultation underway (9 pages, 177 KB) 05 May 2008
- Trastuzumab (Herceptin) timeline (2 pages, 32 KB) 05 May 2008
- Matthew Brougham appointed PHARMAC’s Chief Executive (1 page, 74 KB) 16 Apr 2008
- New PHARMAC website designed to meet users' needs (1 page, 17 KB) 14 Apr 2008
- Herceptin Court judgement reassuring (2 pages, 71 KB) 03 Apr 2008
- Trastuzumab/Herceptin Judgement 3 April 2008 (74 pages, 186 KB) 02 Apr 2008
Page updated on 10 Jun 2008
Linked documents
Herceptin consultation ends (3 pages, 121 KB)
Consultation on PHARMAC’s proposal to decline funding for 12 months treatment with the breast cancer drug Herceptin ends today, with more than 300 submissions received. CEO Matthew Brougham says that given the…
New migraine treatment could be on the tip of your tongue (1 page, 62 KB)
Wafers that dissolve on the tongue will become a new treatment option for people who suffer from painful migraine headaches from next month. The…
PHARMAC calls for public comment on review of advisory committee guidelines (1 page, 83 KB)
PHARMAC is reviewing the guidelines under which its main clinical advisory committee operates.
Hit the target - Antibiotic Campaign 2008 (2 pages, 280 KB)
Media Release Make sure you don’t miss the target with antibiotic use – PHARMAC New Zealanders are being urged to ensure their antibiotic use is well targeted, with the launch of the PHARMAC-led Wise Use of Antibiotics campaign today. In…
Prescribing decline a healthy trend - PHARMAC (1 page, 720 KB)
Media Release Prescribing decline a healthy trend - PHARMAC A continuing decline in prescription figures for the most commonly used antibiotics is a healthy sign, says PHARMAC’s Medical Director Dr Peter Moodie. PHARMAC has today launched the 11th annual Wise…
Herceptin consultation underway (9 pages, 177 KB)
PHARMAC has today begun consulting on a proposal to decline funding for 12 months’ treatment for HER2 positive early breast cancer with Herceptin. The consultation is a result of the High Court…
Matthew Brougham appointed PHARMAC’s Chief Executive (1 page, 74 KB)
Matthew Brougham has been appointed as PHARMAC’s Chief Executive. The appointment confirms Matthew Brougham in the position he has held in an interim capacity since July 2006.
New PHARMAC website designed to meet users' needs (1 page, 17 KB)
A re-designed PHARMAC website is aimed at helping people better understand the Government drug-funding agency’s work, says Corporate Manager Peter Alsop. The new site, released today, has a completely revised…
Herceptin Court judgement reassuring (2 pages, 71 KB)
Today's High Court judgement on Herceptin gives New Zealanders significant reassurances about PHARMAC's processes and decision making, says PHARMAC’s acting chief executive Matthew Brougham. “PHARMAC has considerable sympathy for women with breast cancer, as…
Trastuzumab/Herceptin Judgement 3 April 2008 (74 pages, 186 KB)
IN THE HIGH COURT OF NEW ZEALAND WELLINGTON REGISTRY CIV 2007-485-1386 UNDER IN THE MATTER OF JUDICATURE AMENDMENT ACT 1972 THE NEW ZEALAND PUBLIC HEALTH & DISABILITY ACT 2000 CHRISTINE MARY MIRIAM WALSH, AMANDA LEIGH RUDD, DIANE BARBARA MCCORMACK, DIANE…
